<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-14T20:28:21Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/ggy5rrpgjs.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/ggy5rrpgjs.1</identifier>
                <datestamp>2025-04-25T09:53:17Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>xie, guojiao</dc:creator>
    <dc:title>Biochemical properties of PD-L1 ubiquitination by CRL3SPOP, ARIH1 and NEDD4 family ubiquitin ligases</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>As a key immune checkpoint ligand, PD-L1 represents a critical target in cancer immunotherapy. While multiple E3 ubiquitin ligases including CRL3SPOP, ARIH1, and NEDD4 have been implicated in PD-L1 degradation, their precise enzymatic mechanisms remain unclear.  Through in vitro reconstitution with purified components, we systematically compared the enzymatic activities of CRL3SPOP, ARIH1, and NEDD4 ligases on PD-L1&apos;s cytoplasmic domain. ARIH1, rather than CRL3SPOP, could independently ubiquitinate PD-L1. We demonstrated a unique mechanism that ARIH1 acts as a substrate receptor to cooperate with CRLs to catalyze PD-L1 ubiquitination. We also biochemically validated the E3 ligase activity of the NEDD4 family E3s towards PD-L1. Using liposomes in the enzymatic assays, we illustrated that the phosphorylation enhanced PD-L1 ubiquitination by disrupting its membrane association. Our study provides previously neglected biochemical insights into PD-L1 ubiquitination, which advances our understanding of the molecular details of PD-L1 regulation mechanism. </dc:description>
    <dc:subject>Cancer Immunology</dc:subject>
    <dc:subject>Programmed Death-Ligand 1</dc:subject>
    <dc:subject>Ubiquitin Ligase</dc:subject>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/ggy5rrpgjs.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/ggy5rrpgjs.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/ggy5rrpgjs</dc:relation>
    <dc:date>2025-04-25T09:53:17Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
